Skip to content

Direxion™ M001195340Recalls & reported problems

Boston Scientific Corporation · Torqueable Microcatheter · Class 2

All models of Direxion (14)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729839453), received between Sep 27, 2018 and Dec 16, 2025 — classified as 4 malfunctions.

The most frequently reported specific device problem is “Fracture” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Fracture2
  • Adverse Event Without Identified Device or Use Problem1
  • Break1
  • Defective Device1
  • Difficult to Open or Remove Packaging Material1
  • Material Deformation1
  • Nonstandard Device1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • No Consequences Or Impact To Patient2

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 16, 2025Fracture; Nonstandard Device; Fracture; Nonstandard Device

    IT WAS REPORTED THAT THE DEVICE FRACTURED. THE TARGET LESION WAS LOCATED IN THE LIVER. A DIREXION MICROCATHETER WAS SELECTED FOR TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE). HOWEVER, DURING COIL ADVANCING, A FRACTURE OCCURRED AT THE CONNECTION POINT OF THE MICROCATHETER'S DISTAL END. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS AS A RESULT OF THIS EVENT, AND THE PATIENT WAS STABLE POST-PROCEDURE. IT WAS FURTHER REPORTED THAT THE ROTATION AT THE END FRACTURED. NO FRACTURED DEVICE WAS INSIDE THE PATIENT BECAUSE IT WAS COMPLETELY REMOVED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23817174 ↗
  • MalfunctionApr 5, 2024Defective Device; Difficult to Open or Remove Packaging Material; Material Deformation; Adverse Event Without Identified Device or Use Problem; Defective Device; Difficult to Open or Remove Packaging Material; Material Deformation; Adverse Event Without Identified Device or Use Problem

    REPORTABLE UPON ANALYSIS COMPLETED 21MARCH2024. IT WAS REPORTED THAT THIS MICROCATHETER HAD KINKED. DURING IMAGING OF A RENAL EMBOLIZATION PROCEDURE USING A DIREXION MICROCATHETER, IT WAS FOUND THAT THE DEVICE WAS FAULTY DURING TRACKING THOUGH THE ANATOMY AND THE HUB HAD KINKED. IT WAS NOTED THAT THE CARRIER TUBE WAS HYDRATED PRIOR TO THE REMOVAL OF THE CATHETER; HOWEVER, THERE WAS A LITTLE RESISTANCE REMOVING THE CATHETER FROM THE CARRIER TUBE. A NEW DEVICE WAS USED TO COMPLETE THE PROCEDURE, AND NO PATIENT COMPLICATIONS WERE REPORTED. HOWEVER, DEVICE ANALYSIS REVEALED A FRACTURE AND A DEVICE SEPARATION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19049957 ↗
  • MalfunctionMay 11, 2020Break; Break

    IT WAS REPORTED THAT THE CATHETER SPLIT. A 130 DIREXION CATHETER WAS SELECTED FOR USE IN A HEPATIC ARTERY CHEMOEMBOLIZATION PROCEDURE. DURING PROCEDURE, IT WAS NOTED THAT THE MID-SECTION OF THE CATHETER RIPPED AND SPLIT WHILE DELIVERING THE CHEMO-AGENT. THE DEVICE WAS REMOVED, AND THE PROCEDURE WAS COMPLETED WITH ANOTHER DIREXION. THERE WERE NO PATIENT COMPLICATIONS AND THE PATIENT WAS FINE THROUGHOUT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10042846 ↗
  • MalfunctionSep 27, 2018Fracture; Fracture

    IT WAS REPORTED THAT THE SHAFT BROKE. THE TARGET LESION WAS LOCATED IN THE SEVERELY TORTUOUS MESENTERICA SUPERIOR. A DIREXION MICROCATHETER WAS USED FOR AN EMBOLIZATION PROCEDURE. DURING THE PROCEDURE, IT WAS NOTED THAT THE NITINOL SHAFT OF THE MICROCATHETER BROKE INSIDE THE PATIENT. THE PROCEDURE WAS COMPLETED WITH THIS DEVICE AND THE DEVICE WAS REMOVED. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S CONDITION WAS GOOD. DEVICE EVAL BY MANUFACTURER: RETURNED PRODUCT CONSISTED OF A DIREXION MICROCATHETER. THE SHAFT WAS MICROSCOPICALLY EXAMINED. THE DEVICE SHOWED DAMAGE IN THE FORM OF A SEPARATED SHAFT IN 2 LOCATIONS. THE 1ST LOCATION WAS 43CM FROM THE HUB AND THE 2ND LOCATION WAS 44.2CM FROM THE HUB. THE SHAFT SHOWED SOME SLIGHT BENDS FROM THE TIP PROXIMALLY 12CM. INSPECTION OF THE REMAINDER OF THE DEVICE, APART FROM THE OBSERVED DAMAGE, REVEALED NO OTHER DAMAGE OR IRREGULARITIES.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7914980 ↗

Other Catheter, continuous flush devices

All Catheter, continuous flush devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page